![Gregory S. Wagner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Dr. Gregory S.
Wagner is Senior Vice President-Research & Development at Resverlogix Corp.
Dr. Wagner was previously employed as Vice President-PreClinical Development by Galileo Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Illinois, a graduate degree from the University of Iowa, and a doctorate degree from the University of Iowa.
Antiguos cargos conocidos de Gregory S. Wagner.
Empresas | Cargo | Fin |
---|---|---|
Galileo Pharmaceuticals, Inc.
![]() Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 01/01/2006 |
RESVERLOGIX CORP. | Corporate Officer/Principal | - |
Formación de Gregory S. Wagner.
University of Iowa | Doctorate Degree |
University of Illinois | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
RESVERLOGIX CORP. | Health Technology |
Empresas privadas | 1 |
---|---|
Galileo Pharmaceuticals, Inc.
![]() Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Gregory S. Wagner